Innovative Genetics

Innovative Genetics is building the infrastructure layer behind the next wave of compliant therapeutics. We develop and license BioIP—fast-acting formulations, nationally trademarked brand systems, compliant packaging, and deployable production infrastructure—designed for scale, structured for recurring revenue, and protected by intellectual property. Our model is entirely non-substance-touching, enabling operators in legal U.S. markets to commercialize without federal exposure or capital-heavy overhead. We generate revenue through licensing, royalties, and infrastructure leasing—without cultivation, manufacturing, or retail.

Innovative Genetics is one of 16 Biotechnology companies we track in South Florida — 2% of the region's 662 startups.